Jocelyne Karam is an Endocrinology/Metabolic physician affiliated with Maimonides Medical Center. OpenAlex indexes 35 publications with 382 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4802 10th Ave
Brooklyn, NY 112192916
Telephone
718-283-5906Registry record last updated 29 Dec 2011.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20251 payment
- ABBVIE INC.Program year20251 payment
- Xeris Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
46%Biguanide (metformin)15.5%Metformin Hcl89%Metformin Hcl Er11%Part D<11 patientsGLP-1 receptor agonist10.2%Ozempic62%Mounjaro19%Trulicity19%Part D<11 patients+ 6 more classes in this area
Cardiovascular
28.3%Statin12.3%Atorvastatin Calcium37%Rosuvastatin Calcium37%Pravastatin Sodium27%Part D<11 patientsCalcium channel blocker7.7%Amlodipine Besylate100%Part D≥14 patients+ 3 more classes in this area
Hormonal (systemic)
25.8%l-Thyroxine25.8%Synthroid66%Levothyroxine Sodium34%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 8105 Radiation-Induced Hyperthyroidism in the Context of Palliative Radiation Therapy
Journal of the Endocrine Society
2024 - 8088 Connecting the Dots: Semaglutide, Constipation, and Diverticulitis - A case report
Journal of the Endocrine Society
2024 - 8233 Cushing Disease Presenting As Severe Persistent Hypokalemia
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Norbert Moskovits, MD
Maimonides Medical Center
Jordan Gitlin, MD
Maimonides Medical Center
Bernadine Donahue, MD
Maimonides Medical Center
Jacob Shani, MD
Maimonides Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”